Reapplix, a European company focused on the biological treatment of diabetic foot ulcers, sought to expand into the U.S. market with its 3C Patch System—an autologous therapy for hard-to-heal foot ulcers.

After conducting market research, analyzing the competitive landscape, and interviewing medical professionals, it was clear that the product's ease of use and its autologous nature were key differentiators.

With only color and typography as brand guidelines, new messaging and visuals needed to be developed. For the first phase of the soft launch at a trade show, a booth and product literature were created to quickly communicate the value of the Reapplix 3C Patch System. The creative approach balanced simplicity and clarity while still telling the product's full story.

Initially branded as LeucoPatch, the product was rebranded as 3C Patch. This new name, inspired by the soft launch messaging, emphasized the product's ease of use by highlighting the three-step process, the three-layer patch, and the three-phase system.